Their study found that triple therapy with aprepitant reduced the incidence of PONV as compared to dual-agent prophylaxis with ondansetron and dexamethasone, but the difference did not reach statistical significance.
← all excerpts
Comparison of aprepitant, dexamethasone, and ondansetron with dexamethasone and ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic surgeries: a randomized controlled trial in India.
1
—
—